Skip to main content
. 2012 Sep 26;3:404–420. doi: 10.7150/jca.4956

Figure 4.

Figure 4

Figure 4

Figure 4

Figure 4

GC-ToFMS analysis of bladder cancer (BC) patient and healthy control (H): (A) TIC of BC patient (top) and healthy control (bottom), (B) OPLS-DA scores plot differentiating BC patients and healthy controls, (C) validation plot from 100 permutation tests and (D) receiver operating characteristic (ROC) calculated from validated Y-predicted values of PLS-DA model (reproduced with permission from 82)